WASHINGTON — Patients For Affordable Drugs Now kicks off a campaign today calling on Rep. Marilyn Strickland (WA-10) to support swift passage of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a comprehensive package of drug pricing reforms that includes allowing Medicare to negotiate lower prices for Washingtonians. The campaign includes digital advertising and grassroots advocacy urging Rep. Strickland to deliver on her campaign promise “to give Medicare the power to negotiate drug prices, forcing pharmaceutical companies to lower prices across the board.”
“Our message to Rep. Strickland is clear: You have a choice. You can stand with Big Pharma, which is fighting against lower drug prices for your constituents, or stand with patients as you promised during your campaign,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Allowing Medicare to negotiate lower drug prices enjoys overwhelming bipartisan support from 88 percent of Americans. Washingtonians need Rep. Strickland to lend her full support to H.R. 3 — the principal Medicare negotiation bill in the House of Representatives — to ensure we get affordable medicines we need now and innovation for the future.”
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching simultaneously in 42 House districts across 22 states and in D.C. It comes on the heels of Big Pharma’s recent attack adloaded with lies about H.R. 3.